Toqa Alabyadh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Toqa Alabyadh has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Abbas Rahdar
Department of Physics, University of Zabol, Zabol, Iran
1 shared publication - Ali Es-Haghi
Department of Biology, Mashhad branch, Islamic Azad university, Mashhad, Iran
1 shared publication - Mohammad Ehsan Taghavizadeh Yazdi
Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
1 shared publication - Narges Ajalli
Department of Chemical Engineering, Faculty of Engineering, University of Tehran, Tehran 1417935840, Iran
1 shared publication - Riyadh Albadri
Department of Biology, Mashhad Branch, Islamic Azad University, Mashhad 91871-47578, Iran
1 shared publication - Vijay Kumar Thakur
Biorefining and Advanced Materials Research Center, SRUC, Edinburgh EH9 3JG, UK
1 shared publication
Latest Publications
- Open Access
- 2 September 2022
- Published by MDPI AG in Journal of Functional Biomaterials
- Vol. 13 (3) , 139
ZnO/CeO2 Nanocomposites: Metal-Organic Framework-Mediated Synthesis, Characterization, and Estimation of Cellular Toxicity toward Liver Cancer Cells
The Zinc-doped cerium oxide nanocomposite (ZnO/CeO2 NC) was synthesized using a metal-organic framework as a precursor through the combustion method. It was characterized by powder X-ray diffraction (PXRD), Fourier transform infrared spectroscopy (FTIR), field emission electron microscopy (FESEM), energy dispersive analysis (EDX), transmission electron microscopy (TEM), dynamic light scattering (DLS), and ξ-potential. The PXRD demonstrated the successful synthesis of ZnO/CeO2 NC with a crystallite size of 31.9 nm. FESEM and TEM images displayed hexagonal and spherical morphologies, and the solid-phase size was 65.03 ± 30.86 nm for ZnO/CeO2 NCs. DLS, TEM, and FESEM showed that the NCs have a high tendency for agglomeration/aggregation in both aqueous media and solid phase. The anticancer attributes of ZnO/CeO2 NC were investigated against Liver cancer cells (HepG2), which showed inhibition of cancer cell growth on a concentration-dependent gradient. The cell toxicity effects of ZnO/CeO2 nanocomposites were also studied toward NIH-3T3, in which the data displayed the lower toxicity of NC compared to the HepG2 cell line.
- 2 September 2022
- Published by MDPI AG in Journal of Functional Biomaterials
- Vol. 13 (3) , 139
Open AccessZnO/CeO2 Nanocomposites: Metal-Organic Framework-Mediated Synthesis, Characterization, and Estimation of Cellular Toxicity toward Liver Cancer Cells
The Zinc-doped cerium oxide nanocomposite (ZnO/CeO2 NC) was synthesized using a metal-organic framework as a precursor through the combustion method. It was characterized by powder X-ray diffraction (PXRD), Fourier transform infrared spectroscopy (FTIR), field emission electron microscopy (FESEM), energy dispersive analysis (EDX), transmission electron microscopy (TEM), dynamic light scattering (DLS), and ξ-potential. The PXRD demonstrated the successful synthesis of ZnO/CeO2 NC with a crystallite size of 31.9 nm. FESEM and TEM images displayed hexagonal and spherical morphologies, and the solid-phase size was 65.03 ± 30.86 nm for ZnO/CeO2 NCs. DLS, TEM, and FESEM showed that the NCs have a high tendency for agglomeration/aggregation in both aqueous media and solid phase. The anticancer attributes of ZnO/CeO2 NC were investigated against Liver cancer cells (HepG2), which showed inhibition of cancer cell growth on a concentration-dependent gradient. The cell toxicity effects of ZnO/CeO2 nanocomposites were also studied toward NIH-3T3, in which the data displayed the lower toxicity of NC compared to the HepG2 cell line.